qpatch automated patch-clamp platform (Sophion Bioscience)
Structured Review

Qpatch Automated Patch Clamp Platform, supplied by Sophion Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qpatch+automated+patch+clamp+platform/qpatch+16+automated+electrophysiology+platform/pmc11808707-32-55-59
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Analgesia and peripheral c-fiber modulation by selective Na v 1.8 inhibition in rhesus"
Article Title: Analgesia and peripheral c-fiber modulation by selective Na v 1.8 inhibition in rhesus
Journal: Pain
doi: 10.1097/j.pain.0000000000003404
Figure Legend Snippet: Na v channel compound profile assessed on the Qube or Qpatch*. Ten-point titrations in the Qube automated patch-clamp assay determined MSD199 to be a potent and selective compound (IC 50 = 4.7 ± 0.8 nM, mean ± SD). MSD199 potency was too weak to calculate for all other Na v isoforms except Na v 1.4, which was 1781-fold shifted to 8370 nM mean IC 50 ± 1429.
Techniques Used: Patch Clamp
Related Articles
other:Article Title: Simultaneous assessment of compound activity on cardiac Nav1.5 peak and late currents in an automated patch clamp platform. Article Snippet: Introduction: High throughput in vitro profiling of the cardiac Nav1.5 peak sodium current (INa) is widely used in cardiac safety screening.. However, there is no standardized high throughput method to measure late INa.. This study assessed the pharmacological and biophysical properties of veratridine and ATX-II, as well as the channel mutation (Nav1.5-∆KPQ) on the late INa. |